4/15
07:10 am
tffp
TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions [Yahoo! Finance]
High
Report
TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions [Yahoo! Finance]
4/15
07:00 am
tffp
TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
Medium
Report
TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
4/1
07:53 am
tffp
TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations [Yahoo! Finance]
Low
Report
TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations [Yahoo! Finance]
3/28
05:32 pm
tffp
TFF Pharmaceuticals GAAP EPS of -$2.01, revenue of $0.1M [Seeking Alpha]
Medium
Report
TFF Pharmaceuticals GAAP EPS of -$2.01, revenue of $0.1M [Seeking Alpha]
3/28
04:19 pm
tffp
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/28
04:05 pm
tffp
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Medium
Report
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
3/27
04:09 pm
tffp
TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs [Yahoo! Finance]
High
Report
TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs [Yahoo! Finance]
3/27
04:01 pm
tffp
TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs
Medium
Report
TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs
3/25
09:13 am
tffp
TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I
Medium
Report
TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I
3/25
09:01 am
tffp
TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I
Medium
Report
TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I
3/22
03:11 pm
tffp
TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Low
Report
TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
3/20
12:10 pm
tffp
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
Medium
Report
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
3/20
12:00 pm
tffp
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
High
Report
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
3/20
09:19 am
tffp
TFF Pharmaceuticals Announces Update on Clinical Programs [Yahoo! Finance]
High
Report
TFF Pharmaceuticals Announces Update on Clinical Programs [Yahoo! Finance]
3/20
09:03 am
tffp
TFF Pharmaceuticals Announces Update on Clinical Programs
High
Report
TFF Pharmaceuticals Announces Update on Clinical Programs
3/14
04:56 pm
tffp
TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024 [Yahoo! Finance]
Medium
Report
TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024 [Yahoo! Finance]
3/14
04:47 pm
tffp
TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024
Medium
Report
TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024